Revive Therapeutics Ltd RVVTF
$0.02 $0.00 (13.81%) 1D
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
RVVTF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Revive Therapeutics Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Revive Therapeutics Ltd. Stock Analysis RVVTF
United States Health Care Nano Cap Revive Therapeutics Ltd. engages in the research, development, and commercialization of drugs for disorders and infectious diseases. The company is headquartered in Toronto, Ontario. The company went IPO on 2013-07-12. The firm is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. The company is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The firm is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The firm's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
Revive Therapeutics Ltd (RVVTF) Chart
Financial Metrics & Statements of Revive Therapeutics Ltd (RVVTF)
FAQ's for Revive Therapeutics Ltd (RVVTF)
- As of August 2026, Revive Therapeutics Ltd RVVTF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Revive Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Revive Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Revive Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Revive Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Revive Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Revive Therapeutics Ltd (RVVTF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
